XtalPi and CK Life Sciences to develop AI-driven tumour vaccine R&D platform
Asia-Pacific
Japan’s MHLW approves Daiichi Sankyo’s breast cancer treatment
The approval was based on findings from the Phase III DESTINY-Breast03 trial of Enhertu.
Japan grants emergency regulatory approval for Shionogi’s Covid-19 drug
Chinese manufacturers’ transition to innovative pharma requires more investment
RVAC Medicines, A*STAR partner for mRNA manufacturing expertise
Warnings for Japanese pharmaceutical market may lead to more lenient price controls
China NMPA approves Ascletis’ IND for advanced solid tumours therapy
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
